0001213900-23-075377.txt : 20230908
0001213900-23-075377.hdr.sgml : 20230908
20230908160045
ACCESSION NUMBER: 0001213900-23-075377
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230904
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAY RUSSELL T
CENTRAL INDEX KEY: 0001225960
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 231245246
MAIL ADDRESS:
STREET 1: 2525 DUPONT DR
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 EL CAMINO REAL
STREET 2: BLDG 4, STE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-507-0669
MAIL ADDRESS:
STREET 1: 3000 EL CAMINO REAL
STREET 2: BLDG 4, STE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0508
4
2023-09-04
0
0001690080
180 Life Sciences Corp.
ATNF
0001225960
RAY RUSSELL T
3000 EL CAMINO REAL, BLDG. 4,
SUITE 200
PALO ALTO
CA
94306
1
0
0
0
0
Common Stock
2023-09-04
4
A
0
21455
1.36
A
24409
D
Non-Qualified Stock Option (right to buy)
0.67
2023-09-04
4
A
0
15000
0.0
A
2033-09-04
Common Stock
15000
15000
D
Issued in consideration for serving on the Board of Directors and as a Member of the Audit, Compensation and Nominating and Corporate Governance Committees of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.
/s/ Russell T. Ray
2023-09-08